Cora Gold CEO Bert Monro Talks Through Sanankoro’s Fast-Track to Production and Major Upside Potential
Verge Technologies: Delivering zero-downtime database resilience in a multi-cloud world 28 November 2025
Meren Energy $100M Dividends and Debt Slashed as Nigerian and Namibian Oil Assets Power Ahead (Video)
Panmure Liberum Highlights Cerillion’s Expanding Pipeline and Strengthening Growth Outlook 1 December 2025
Strix Group Sharpens Focus on Shareholder Value and Debt Reduction – Equity Development 26 November 2025
Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT) 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer 16 December 2025
Syncona Limited (SYNC.L) Stock Analysis: Exploring a Potential 115% Upside in Asset Management 18 December 2025
SSP GROUP PLC (SSPG.L) Stock Analysis: A 14.81% Potential Upside Amidst Global Expansion 18 December 2025
Dowlais Group PLC (DWL.L) Stock Analysis: Navigating Challenges with a 5% Dividend Yield 18 December 2025
SUPERMARKET INCOME REIT PLC ORD (SUPR.L): Investor Outlook and a 7.79% Dividend Yield 18 December 2025
Cora Gold CEO Bert Monro Talks Through Sanankoro’s Fast-Track to Production and Major Upside Potential
Verge Technologies: Delivering zero-downtime database resilience in a multi-cloud world 28 November 2025
Meren Energy $100M Dividends and Debt Slashed as Nigerian and Namibian Oil Assets Power Ahead (Video)
Panmure Liberum Highlights Cerillion’s Expanding Pipeline and Strengthening Growth Outlook 1 December 2025
Strix Group Sharpens Focus on Shareholder Value and Debt Reduction – Equity Development 26 November 2025
Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT) 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
AstraZeneca’s Enhertu plus pertuzumab approved in US for 1st-line HER2-positive breast cancer 16 December 2025
Syncona Limited (SYNC.L) Stock Analysis: Exploring a Potential 115% Upside in Asset Management 18 December 2025
SSP GROUP PLC (SSPG.L) Stock Analysis: A 14.81% Potential Upside Amidst Global Expansion 18 December 2025
Dowlais Group PLC (DWL.L) Stock Analysis: Navigating Challenges with a 5% Dividend Yield 18 December 2025
SUPERMARKET INCOME REIT PLC ORD (SUPR.L): Investor Outlook and a 7.79% Dividend Yield 18 December 2025
Integer Holdings Corporation (ITGR) Stock Analysis: A 29.83% Upside Potential in the Medical Devices Sector 28 July 2025
Tempus AI, Inc. (TEM) Stock Analysis: Harnessing a Robust 75.4% Revenue Growth in Health Information Services 28 July 2025
Bausch + Lomb Corporation (BLCO) Stock Report: Navigating a 1.01% Potential Upside Amidst Healthcare Growth 28 July 2025
Madrigal Pharmaceuticals (MDGL) Stock Analysis: Navigating a Promising 42% Upside in the Biotech Sector 28 July 2025
Penumbra, Inc. (PEN) Stock Analysis: Unveiling a 33.82% Potential Upside in the Medical Devices Sector 28 July 2025
Legend Biotech Corporation (LEGN) Stock Analysis: Unveiling a 75.95% Potential Upside in the Biotechnology Sector 28 July 2025
Charles River Laboratories (CRL) Stock Analysis: Navigating a Transitional Phase with Insightful Market Indicators 28 July 2025
Bristol-Myers Squibb (BMY): Analyst Ratings Signal 15.73% Upside Potential for Investors 28 July 2025
Alnylam Pharmaceuticals (ALNY): Analyst Consensus Highlights Strong Buy Ratings Amid Robust Pipeline 28 July 2025
CVS Health Corporation (CVS): Rating Update Reveals 30% Potential Upside, Making It a Buy for Investors 28 July 2025
Inspire Medical Systems, Inc. (INSP) Stock Analysis: Navigating a 61.65% Potential Upside 28 July 2025
Roivant Sciences Ltd. (ROIV) Stock Analysis: Potential 47% Upside Amid Biotech Innovations 28 July 2025
Chemed Corp (CHE) Stock Analysis: Exploring a 29.59% Potential Upside in the Healthcare Sector 28 July 2025
Verona Pharma plc (VRNA) Stock Analysis: Navigating the Biotech Terrain with a $8.95 Billion Market Cap 28 July 2025
Prestige Consumer Healthcare (PBH) Stock Analysis: A 15% Upside Potential Amid Steady Growth 28 July 2025
Elanco Animal Health (ELAN) Stock Analysis: Investor Outlook Reveals 4.19% Potential Upside 28 July 2025
NB Private Equity Partners: Buybacks, Exits and a Quiet Rebound Investors Are Missing (Video) 24 November 2025
Verge Technologies: Why SentientDB Is Mission-Critical in a Multi-Cloud World (Video) 24 November 2025
Cavendish Plc Market Resilience, Deep Value, and a 7.5% Yield That’s Hard to Ignore (Video) 24 November 2025
Meren Energy $100M Dividends and Debt Slashed as Nigerian and Namibian Oil Assets Power Ahead (Video) 19 November 2025
Harbour Energy to acquire Waldorf subsidiaries in $170m deal, boosting UK production 12 December 2025
TwentyFour Income Fund reports positive month as ABS and CLO issuance hits post-crisis highs 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
Cora Gold CEO Bert Monro Talks Through Sanankoro’s Fast-Track to Production and Major Upside Potential 2 June 2025
Verge Technologies: Delivering zero-downtime database resilience in a multi-cloud world 28 November 2025
Panmure Liberum Highlights Cerillion’s Expanding Pipeline and Strengthening Growth Outlook 1 December 2025
Strix Group Sharpens Focus on Shareholder Value and Debt Reduction – Equity Development 26 November 2025
Global Opportunities Trust reaffirms successful value and absolute-return strategy (LON: GOT) 12 December 2025
Prediction markets move into the mainstream as trading surges | Ruffer Investment Company 12 December 2025
Syncona Limited (SYNC.L) Stock Analysis: Exploring a Potential 115% Upside in Asset Management 18 December 2025
SSP GROUP PLC (SSPG.L) Stock Analysis: A 14.81% Potential Upside Amidst Global Expansion 18 December 2025
Dowlais Group PLC (DWL.L) Stock Analysis: Navigating Challenges with a 5% Dividend Yield 18 December 2025
SUPERMARKET INCOME REIT PLC ORD (SUPR.L): Investor Outlook and a 7.79% Dividend Yield 18 December 2025
